Last updated: 4 months ago
Evaxion Biotech A/S: Phase 2 Trial Success for AI-Powered Cancer Vaccine EVX-01
Discover Evaxion Biotech A/S's latest report on the successful completion of dosing in the phase 2 trial for EVX-01, an innovative personalized cancer vaccine. Key developments inside.